Documento fuente o registro público

FDA 510(k) K252114 — MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL

FDA 510(k) index record K252114. Device: MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL. Applicant as listed: Liofilchem s.r.l.. Decision date: 2025-10-02.

OtherU.S. Food and Drug Administration (FDA)2025-10-02

Fuente

"device_name": "MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-24

Disclaimer

professional use

FDA 510(k) public index record K252114.

Device name: MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL. Applicant as listed: Liofilchem s.r.l..

Decision date: 2025-10-02. Decision wording: Substantially Equivalent.

Product code: JWY. Regulation: 21 CFR 866.1640. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más